The Medical Devices Regulations 2002, 5

Interpretation of Part II

In forcesince 21 Mar 2010cited 3×
(1)

In this Part …—

“accessory” means an article which, whilst not being a medical device, is intended specifically by its manufacturer to be used together with a medical device to enable it to be used in accordance with the use of the medical device intended by its manufacturer;

“custom-made device” means a relevant device that is—

manufactured specifically in accordance with a written prescription of a registered medical practitioner, or other person authorised to write such a prescription by virtue of his professional qualification, which gives, under his responsibility, specific characteristics as to its design; and

intended for the sole use of a particular patient,

but does not include a mass-produced product which needs to be adapted to meet the specific requirements of the medical practitioner or professional user;

“relevant device” shall be construed in accordance with regulation 6;

“single-use combination product” means a product which comprises a medical device and medicinal product forming a single integral product which is intended exclusively for use in the given combination and which is not reusable; and

“system or procedure pack” has the same meaning as in article 12 of Directive 93/42.

(2)

In this Part …, a reference to a numbered article or Annex is to the article or Annex of Directive 93/42 bearing that number.

  • The Medical Devices (Amendment) Regulations 20034Law

    In regulation 5(1) and (2) of the principal Regulations (interpretation of Part II), the words “, unless the context otherwise requires” are omitted.

  • The Medical Devices (Amendment) Regulations 2008Law

    … provisions of Directive 90/385/EC to bring this in line with those set out in Directive 93/42/EC. Regulation 4 amends regulation 5 of the principal Regulations to include reference to a duly qualified healthcare practitioner writing …

  • The Medical Devices (Fees Amendment) Regulations 2017Law

    … bodies to the Secretary of State where a notified body is assessing a device manufactured using animal tissue. Regulation 5 introduces a new fee in connection with amendments made to clinical investigation notices submitted to the …